Efficacy And Safety Of Perioperative Flot (5-Fu, Lv, Oxaliplatin, Docetaxel) Chemotherapy In Gastric And Gastroesophageal Junction Adenocarcinoma: Real-Life Data From Turkish Oncology Group

C. Erol, T. Basoglu, A. Sakin,E. Ozden, D. Cubuk,P. F. Yumuk, M. Dogan, B. Oksuzoglu, H. C. Yildirim, I. Oner,M. Karakurt Eryilmaz, O. Dulgar, E. Turkmen Bekmez, N. Dogan, M. Ozen, F. Gurler,N. Paksoy,A. Aksoy, M. Hizal, M. A. N. Sendur

ANNALS OF ONCOLOGY（2021）

引用 0|浏览0

暂无评分

摘要

FLOT regimen has been considered for early satage gastric and gastroesophageal junction (GEJ) adenocarcinoma for perioperative treatment because of its more tolerability and better response rates in metastatic disease and significant overall survival (OS) and disease free survival (DFS) advantage to ECF regimen. We aimed to determine the real-life efficacy and safety of perioperative FLOT regimen in gastric and GEJ cancer patients.

查看译文

关键词

perioperative flot,chemotherapy,turkish oncology group,junction adenocarcinoma,real-life

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要